Snibe Co., Ltd.

Since its establishment in 1995, Snibe has contributed to the development of the IVD field through Chemiluminescence immunoassay products.

Focusing on Chemiluminescence immunoassay solutions over 28 years, Snibe’s total installations currently reach 23900 units, with products exported to more than 150 countries globally. At present, Snibe has 3 main product lines: Immunoassay, Clinical chemistry and Molecular diagnosis, providing diversified total laboratory automation solutions.

Meanwhile, Snibe’s Auto-immunoassay analyzer Maglumi X8 has the fastest throughput which can reach up to 600 tests per hour. Moreover, Snibe owns a broad CLIA test menu of up to 194 parameters, as well as a fully automated production line with annual productivity of 4 million reagent kits.

Outstanding product quality is inseparable from the support of brilliant talents. In pursuing the best quality and best service, Snibe has established Reagents R & D and production center, Instruments R & D and production center, and Sales & Marketing center to form a strong team of professionals, among which professional R & D personnel accounts for more than 16%.

To be the pioneer in the global diagnosis field is our vision. Snibe's striving for excellence never ends.